Open-Label Study of the Long Term Tolerability and Safety of Atomoxetine in Children With FASD and ADD/ADHD

NCT00418262 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

27

Enrollment

OTHER

Sponsor class

Conditions

Fetal Alcohol Syndrome
Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

DRUG: Atomoxetine

Sponsor

University of Oklahoma

Collaborators

[object Object]